Concomitant resistance and early-breast cancer: should we change treatment strategies?

Diabetes in relation to breast cancer relapse and all-cause mortality in elderly breast cancer patients: a FOCUS study analysis

(2013) M. Kiderlen et al.   ANNALS OF ONCOLOGY

Preclinical evaluation of zoledronate using an in vitro mimetic cellular model for breast cancer metastatic bone disease

(2013) P.G. Dedes et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and “swarm intelligence”

(2013) M. Tarabichi et al.   CANCER AND METASTASIS REVIEWS

The anticancer effect of phospho-tyrosol-indomethacin (MPI-621), a novel phosphoderivative of indomethacin: in vitro and in vivo studies

(2013) Dingying Zhou et al.   CARCINOGENESIS

Safety and therapeutic effect of metronomic chemotherapy with cyclophosphamide and celecoxib in advanced breast cancer patients

(2013) Herman A Perroud et al.   Future Oncology

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials

(2013)   LANCET

Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial

(2013) Dino Amadori et al.   LANCET ONCOLOGY

Immunogenic Cell Death in Cancer Therapy

(2012) Guido Kroemer et al.   Annual Review of Immunology

Antitumor activity of zoledronic acid in primary breast cancer cells determined by the ATP tumor chemosensitivity assay

(2012) Tanja Fehm et al.   BMC CANCER

NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup

(2012) Michael Retsky et al.   BREAST CANCER RESEARCH AND TREATMENT

Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study

(2012) Saroj Niraula et al.   BREAST CANCER RESEARCH AND TREATMENT

Molecular characterization of circulating tumor cells in breast cancer: challenges and promises for individualized cancer treatment

(2012) Evi S. Lianidou et al.   CANCER AND METASTASIS REVIEWS

Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials

(2012) François-Clément Bidard et al.   CANCER AND METASTASIS REVIEWS

Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid

(2012) Gabriella Misso et al.   CANCER BIOLOGY & THERAPY

Concomitant Tumor Resistance: The Role of Tyrosine Isomers in the Mechanisms of Metastases Control

(2012) R. A. Ruggiero et al.   CANCER RESEARCH

Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-Dependent and -Independent Mechanisms

(2012) J. K. Singh et al.   CLINICAL CANCER RESEARCH

Bisphosphonates in the Adjuvant Treatment of Breast Cancer

(2012) M.C. Winter et al.   CLINICAL ONCOLOGY

Cancer chemotherapy: A critical analysis of its 60 years of history

(2012) Darío Galmarini et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade

(2012) Leisha A Emens   Expert Review of Anticancer Therapy

NF-κB and the link between inflammation and cancer

(2012) Joseph A. DiDonato et al.   IMMUNOLOGICAL REVIEWS

Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial

(2012) Alexander HG Paterson et al.   LANCET ONCOLOGY

Reappraising antiangiogenic therapy for breast cancer

(2011) Robert S. Kerbel   BREAST

Tyrosine Isomers Mediate the Classical Phenomenon of Concomitant Tumor Resistance

(2011) R. A. Ruggiero et al.   CANCER RESEARCH

Phase II Trial of Neoadjuvant Exemestane in Combination With Celecoxib in Postmenopausal Women Who Have Breast Cancer

(2011) Maryam B. Lustberg et al.   Clinical Breast Cancer

Therapeutic targeting of B7-H1 in breast cancer

(2011) Amal Hasan et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients

(2011) Bahriye Aktas et al.   GYNECOLOGIC ONCOLOGY

Directed Therapy of Subtypes of Triple-Negative Breast Cancer

(2011) L. A. Carey   ONCOLOGIST

Anti-cancer immune response mechanisms in neoadjuvant and targeted therapy

(2011) Carsten Denkert et al.   Seminars in Immunopathology

The Role of the Perioperative Period in Recurrence After Cancer Surgery

(2010) Antje Gottschalk et al.   ANESTHESIA AND ANALGESIA

Do Intraoperative Analgesics Influence Breast Cancer Recurrence After Mastectomy? A Retrospective Analysis

(2010) Patrice Forget et al.   ANESTHESIA AND ANALGESIA

Effect of anaesthetic technique and other perioperative factors on cancer recurrence

(2010) G.L. Snyder et al.   BRITISH JOURNAL OF ANAESTHESIA

Regulatory T cells and breast cancer: implications for immunopathogenesis

(2010) Maria Angelica Ehara Watanabe et al.   CANCER AND METASTASIS REVIEWS

Antiangiogenic strategies in breast cancer management

(2010) Monica Giovannini et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

A randomised trial of mastectomy only versus tamoxifen for treating elderly patients with operable primary breast cancer—Final results at 20-year follow-up

(2010) J. Chakrabarti et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Metronomic chemotherapy: new rationale for new directions

(2010) Eddy Pasquier et al.   Nature Reviews Clinical Oncology

Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer

(2009) C. Falandry et al.   ANNALS OF ONCOLOGY

Hypothesis: primary antiangiogenic method proposed to treat early stage breast cancer

(2009) Michael W Retsky et al.   BMC CANCER

Plasticity of CD4+ FoxP3+ T cells

(2009) Xuyu Zhou et al.   CURRENT OPINION IN IMMUNOLOGY

Accumulation of regulatory T cells in sentinel lymph nodes is a prognostic predictor in patients with node-negative breast cancer

(2009) Rikiya Nakamura et al.   EUROPEAN JOURNAL OF CANCER

Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England

(2009) Bernard Rachet et al.   LANCET ONCOLOGY

FOXP3 expression of micrometastasis-positive sentinel nodes in breast cancer patients

(2009) Matsuura   ONCOLOGY REPORTS

Tumor dormancy and immunoescape 

(2008) BRUNO QUESNEL   APMIS

FOXP3+ Tregs and B7-H1+/PD-1+T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy

(2008) Hazem Ghebeh et al.   BMC CANCER

Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer

(2008) Masahiro Ohara et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Tumor Escape Mechanism Governed by Myeloid-Derived Suppressor Cells

(2008) S. Nagaraj et al.   CANCER RESEARCH

Impact of Immediate Versus Delayed Axillary Node Dissection on Surgical Outcomes in Breast Cancer Patients With Positive Sentinel Nodes: Results From American College of Surgeons Oncology Group Trials Z0010 and Z0011

(2008) John A. Olson et al.   JOURNAL OF CLINICAL ONCOLOGY

Correlation between NK function and response to trastuzumab in metastatic breast cancer patients

(2008) Alessandra Beano et al.   Journal of Translational Medicine